Supraflex Cruz evidence presented at TCT 2025
In November 2025, EUKON shared an update from Sahajanand Medical…
Medical Area
Therapeutic Area
🚀 03 Feb 2026 — The AGCM (Italian Competition Authority) has announced an increase in the Legality Rating awarded to EUKON, bringing it to the highest level available: ★★★!
For those working in the cath lab, we keep doing what truly matters: hands-on support, reliability, and continuity.
For public and private procurement teams: this is an additional institutional, clear, and verifiable indicator, supporting supplier qualification and evaluation processes.
Thank you to everyone who chooses us — and to those who challenge us every day. We’re here.
📌 The company is included in the list provided under Art. 8 of the Regulation, available here: https://www.agcm.it/per-le-imprese/rating-di-legalita/elenco-rating
In November 2025, EUKON shared an update from Sahajanand Medical…
In January 2026, EUKON announced the first clinical use in…
EUKON announced the availability of Supraflex Cruz NEVO to Italian…